Anemia is a condition where blood is deficient in red blood cells (RBCs). Pernicious anemia occurs when the body’s capacity to absorb vitamin B12, which is required to make healthy red blood cells, is reduced. It is a rare condition. As per the Journal of Blood Medicine, the prevalence of pernicious anemia is about 0.1% in the normal population, while in aged people (people over 60 years) the prevalence is about 1.9%. Previously, the disease was incurable due to lack of available treatment options. However, it is now easily treatable due to availability of medicines. The symptoms of pernicious anemia are not severe initially, and therefore it is difficult to diagnose. Commonly occurring symptoms include weakness, headaches, weight loss, and in rare cases some neurological problems. The most important sources of vitamin B12 include meat, eggs, poultry, dairy products, and nutritional supplements. In moderate to severe cases, vitamin B12 injections are provided to the patient to counteract deficiency symptoms. Vitamin B12 is available in the form of cyanocobalamin or hydroxocobalamin injections. When vitamin B12 levels are close to normal after treatment with injections, oral doses in the form of pills, sprays, and gels can be provided.

High prevalence of the condition is a major factor likely to drive the global pernicious anemia treatment market during the forecast period. Development of pipeline products, high number of women of reproductive age, unhealthy lifestyle, and complications during pregnancy primarily in developing countries are some of the factors expected to propel the global pernicious anemia treatment market during the forecast period. Furthermore, increase in geriatric population, robust R&D, and improving health care infrastructure are projected to boost the global pernicious anemia treatment market. However, factors such as lack of awareness about health in several developing countries and high cost of drugs are anticipated to restrain the global pernicious anemia treatment market during the forecast period.

The global pernicious anemia treatment market can be segmented based on the route of administration of drug, region, and distribution channel. Based on the route of administration, the pernicious anemia treatment market can be classified into parenteral, oral, nasal, and topical.  The parenteral route segment accounts for a dominant share of the market due to higher availability and stability of drugs in the injectable form and major requirement of drugs in the injectable form during urgencies .In terms of distribution channel, the global pernicious anemia treatment market can be categorized into retail store, pharmacy, and e-commerce. The e-commerce segment is expected to account for a prominent market share in 2025 as shopping online offers convenience to consumers.

Based on region, the global pernicious anemia treatment market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to account for a significant share of the global pernicious anemia treatment market during the forecast period. Rise in incidence of the condition and unhealthy lifestyle are projected to drive the pernicious anemia treatment market in this region. Furthermore, increase in health care expenditure, advanced technology, increase in research activities, and rise in awareness about pernicious anemia are expected to augment the pernicious anemia treatment market in North America. Europe is also anticipated to hold a prominent share of the global pernicious anemia treatment market. The pernicious anemia treatment market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to increase in health care expenditure, rise in geriatric population, surge in disposable income, high prevalence of chronic diseases, increase in awareness, and complications during pregnancy in many rural areas.

Key players operating in the global anemia drugs market are AMAG Pharmaceuticals GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Sanofi, Galenica, Daiichi Sankyo, and Pharmacosmos.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Pernicious Anemia Treatment Market

Pre Book